Hereditary Breast Cancer

Publication Date: August 3, 2021
Last Updated: May 14, 2024

Management

Recommendation 1.1

Germline BRCA status should not preclude a patient with newly diagnosed breast cancer otherwise eligible for breast conserving therapy (BCT) from receiving BCT. ( CB , I , , M )
3336

Overview

Title

Management of Hereditary Breast Cancer

Authoring Organizations

American Society for Radiation Oncology

American Society of Clinical Oncology

Society of Surgical Oncology